Genelink Inc GNLKQ
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 265.02M
- Market Cap
- $10,600.75
- Volume/Avg
- 511,156 / 511,156
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Genelink Inc is a genetics-based, personal healthcare firm that has developed DNA assessments measuring personal DNA tendencies that can have an impact on the overall wellness of an individual. These small differences in DNA, called SNP's (snips) can indicate genetic variants, the protein products of which may not be performing at optimal levels and can be linked to aging and other wellness issues. GeneLink scientists use the DNA assessment information from each client to formulate products to optimize health and wellness within normal ranges. It operates in a single segment of GeneLink, which develops and manufactures genetically customized supplements and skin care products for sale in a variety of market channels.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 15
- Website
- —
Valuation
|
Metric
|
GNLKQ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
GNLKQ
|
|---|---|
Quick Ratio | 0.12 |
Current Ratio | 0.34 |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
GNLKQ
|
|---|---|
Return on Assets (Normalized) | −144.27% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|H#C%H&! | LOCK|$>># | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|LL^Cb! | LOCK|qW^r | $83B | |||
| Moderna Inc
MRNA
| LOCK|%%N>#WZ | LOCK|Hm | $80B | |||
| argenx SE ADR
ARGX
| LOCK|NGp$zy | LOCK|N> | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|x<Byy$ | LOCK|$xh | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|RZz^z$ | LOCK|T!wm | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|PbC!s@^ | LOCK|%%kCX | $28B | |||
| Incyte Corp
INCY
| LOCK|S$zKjB | LOCK|GX | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|SwYX!# | LOCK|&%% | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|qGT?fH | LOCK|K! | $14B |
United States